Abnormal Histones Acetylation in Patients with Primary Sjögren's Syndrome
- 29 January 2022
- journal article
- research article
- Published by Springer Nature in Clinical Rheumatology
- Vol. 41 (5) , 1465-1472
Abstract
Introduction Aberrant histone acetylation is increasingly thought to play important roles in the pathogenesis of autoimmune diseases. However, there are very few data on histone acetylation in primary Sjögren's syndrome (pSS). We aimed to investigate whether there was abnormal histones acetylation in patients with pSS. Methods We investigated the expressions of histone acetyltransferase (HAT) genes (p300, CREBBP and PCAF) by real-time PCR in the peripheral blood mononuclear cells (PBMCs) of pSS patients. HAT activity and histone H3/H4 acetylation activity were measured by activity kit, and histone H3/H4 acetylation was verified by Western blot (WB). Spearman test was utilized to analyze the association between HAT activity levels and clinical parameters of pSS patients. Results The mRNA expressions of p300, CREBBP and PCAF in PBMCs from pSS patients were decreased in comparison with healthy controls (P < 0.05). HAT activity and histone H3/H4 acetylation were reduced in PBMCs from pSS patients (P < 0.05). We found that HAT activity was negatively correlated with CRP (P = 0.040) and TNF-α (P = 0.012), and was positively correlated with C4 (P = 0.041). Conclusions Histone hypoacetylation is observed in patients with pSS and is involved in the pathogenesis of pSS. Key Points: • The mRNA expressions of p300, CREBBP and PCAF in PBMCs from pSS patients were decreased in comparison with HCs. • HAT activity and histone H3/H4 acetylation were reduced in PBMCs from pSS patients. • HAT activity was correlated with disease characters. • We show for the first time that the histone hypoacetylation may be involved in the pathogenesis of pSS.Keywords
Funding Information
- Natural Science Foundation of China (81302565)
- Xiamen Medical and Health Project (3502Z20189009)
This publication has 33 references indexed in Scilit:
- Imbalance between HAT and HDAC Activities in the PBMCs of Patients with Ankylosing Spondylitis or Rheumatoid Arthritis and Influence of HDAC Inhibitors on TNF Alpha ProductionPLOS ONE, 2013
- TNF‐α inhibits aquaporin 5 expression in human salivary gland acinar cells via suppression of histone H4 acetylationJournal of Cellular and Molecular Medicine, 2011
- Histone deacetylases are dysregulated in rheumatoid arthritis and a novel histone deacetylase 3–selective inhibitor reduces interleukin‐6 production by peripheral blood mononuclear cells from rheumatoid arthritis patientsArthritis & Rheumatism, 2011
- Altered miR‐146a expression in Sjögren's syndrome and its functional role in innate immunityEuropean Journal of Immunology, 2011
- The Fms‐like tyrosine kinase 3 ligand, a mediator of B cell survival, is also a marker of lymphoma in primary Sjögren's syndromeArthritis & Rheumatism, 2010
- Role of histone modifications in defining chromatin structure and functionBiological Chemistry, 2008
- Mechanism of HDAC inhibitor FR235222-mediated IL-2 transcriptional repression in Jurkat cellsInternational Immunopharmacology, 2007
- Chromatin modifications and DNA double-strand breaks: the current state of playLeukemia, 2006
- Resetting the Epigenetic Histone Code in the MRL-lpr/lpr Mouse Model of Lupus by Histone Deacetylase InhibitionJournal of Proteome Research, 2005
- CBP and p300: HATs for different occasionsBiochemical Pharmacology, 2004